Literature DB >> 8172861

A definition of initial, fatty streak, and intermediate lesions of atherosclerosis. A report from the Committee on Vascular Lesions of the Council on Arteriosclerosis, American Heart Association.

H C Stary1, A B Chandler, S Glagov, J R Guyton, W Insull, M E Rosenfeld, S A Schaffer, C J Schwartz, W D Wagner, R W Wissler.   

Abstract

The compositions of lesion types that precede and that may initiate the development of advanced atherosclerotic lesions are described and the possible mechanisms of their development are reviewed. While advanced lesions involve disorganization of the intima and deformity of the artery, such changes are absent or minimal in their precursors. Advanced lesions are either overtly clinical or they predispose to the complications that cause ischemic episodes; precursors are silent and do not lead directly to complications. The precursors are arranged in a temporal sequence of three characteristic lesion types. Types I and II are generally the only lesion types found in children, although they may also occur in adults. Type I lesions represent the very initial changes and are recognized as an increase in the number of intimal macrophages and the appearance of macrophages filled with lipid droplets (foam cells). Type II lesions include the fatty streak lesion, the first grossly visible lesion, and are characterized by layers of macrophage foam cells and lipid droplets within intimal smooth muscle cells and minimal coarse-grained particles and heterogeneous droplets of extracellular lipid. Type III (intermediate) lesions are the morphological and chemical bridge between type II and advanced lesions. Type III lesions appear in some adaptive intimal thickenings (progression-prone locations) in young adults and are characterized by pools of extracellular lipid in addition to all the components of type II lesions.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 8172861     DOI: 10.1161/01.atv.14.5.840

Source DB:  PubMed          Journal:  Arterioscler Thromb        ISSN: 1049-8834


  93 in total

Review 1.  Atherosclerotic plaque morphology and coronary thrombi.

Authors:  Allen P Burke; Andrew Farb; Frank D Kolodgie; Jagat Narula; Renu Virmani
Journal:  J Nucl Cardiol       Date:  2002 Jan-Feb       Impact factor: 5.952

2.  Theoretical study of the effect of local flow disturbances on the concentration of low-density lipoproteins at the luminal surface of end-to-end anastomosed vessels.

Authors:  S Wada; M Koujiya; T Karino
Journal:  Med Biol Eng Comput       Date:  2002-09       Impact factor: 2.602

3.  Imaging of unstable atherosclerotic lesions.

Authors:  Jagat Narula; H William Strauss
Journal:  Eur J Nucl Med Mol Imaging       Date:  2005-01       Impact factor: 9.236

4.  Functional melanocortin-2 receptors are expressed by mouse aorta-derived mesenchymal progenitor cells.

Authors:  Jodi F Evans; Anne Fernando; Louis Ragolia
Journal:  Mol Cell Endocrinol       Date:  2012-01-27       Impact factor: 4.102

5.  Histological changes and risk factor associations in type 2 atherosclerotic lesions (fatty streaks) in young adults.

Authors:  Satoki Homma; Dana A Troxclair; Arthur W Zieske; Gray T Malcom; Jack P Strong
Journal:  Atherosclerosis       Date:  2011-07-21       Impact factor: 5.162

6.  Role of endothelial N-glycan mannose residues in monocyte recruitment during atherogenesis.

Authors:  David W Scott; Jie Chen; Balu K Chacko; James G Traylor; Anthony W Orr; Rakesh P Patel
Journal:  Arterioscler Thromb Vasc Biol       Date:  2012-06-21       Impact factor: 8.311

7.  Ex vivo comparison of angioscopy and histopathology for the evaluation of coronary plaque characteristics.

Authors:  Masahiko Shibuya; Kenichi Fujii; Hiroyuki Hao; Takahiro Imanaka; Masashi Fukunaga; Kojiro Miki; Hiroto Tamaru; Tsuyoshi Nakata; Hisashi Sawada; Yoshiro Naito; Seiichi Hirota; Tohru Masuyama
Journal:  Int J Cardiovasc Imaging       Date:  2016-02-12       Impact factor: 2.357

8.  Quantification of Various Inflammatory Cells in Advanced Atherosclerotic Plaques.

Authors:  Veronica Soundra Veena Paul; Christina Mary Priya Paul; Sarah Kuruvilla
Journal:  J Clin Diagn Res       Date:  2016-05-01

9.  Development of a lipoprotein based molecular imaging MR contrast agent for the noninvasive detection of early atherosclerotic disease.

Authors:  L M Mitsumori; J L Ricks; M E Rosenfeld; U P Schmiedl; C Yuan
Journal:  Int J Cardiovasc Imaging       Date:  2004-12       Impact factor: 2.357

10.  Immunohistochemical localization of subtilisin/kexin-like proprotein convertases in human atherosclerosis.

Authors:  Philipp Stawowy; Heike Kallisch; Núbia Borges Pereira Stawowy; Dietger Stibenz; John P Veinot; Michael Gräfe; Nabil G Seidah; Michel Chrétien; Eckart Fleck; Kristof Graf
Journal:  Virchows Arch       Date:  2005-03-09       Impact factor: 4.064

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.